EJS ACT-PD, the world’s largest clinical trial for Parkinson’s, is now recruiting
Cure Parkinson’s is excited to announce that the first multi-arm multi-stage clinical trial platform for Parkinson’s in the UK – EJS ACT-PD – is underway, with recruitment now open to people with Parkinson’s. The Edmond J. Safra Accelerating Clinical Trials for Parkinson’s Disease (EJS ACT-PD)...
Learn more
Corporate partnerships for a cure: Cover Direct supports Cure Parkinson’s
This World Parkinson’s Day, Cure Parkinson’s is pleased to announce a new corporate partnership with insurance provider Cover Direct. Corporate support and partnerships play a vital role in funding crucial research into Parkinson’s, while also helping Cure Parkinson’s raise awareness of the devastating impact this…
Special Update Meeting: The latest on cell replacement therapies for Parkinson’s – watch again
Cure Parkinson’s held a special patient-focused event on Thursday 15 May 2025, which offered a unique opportunity for participants to engage with researchers in this field. Cure Parkinson’s supported the 2025 G-Force PD meeting, an international consortium dedicated to advancing cell replacement therapies for Parkinson’s….
Cure Parkinson’s Ambassador Guy Deacon CBE’s documentary to air on Channel 4
After 18,000 miles, 12 months, 25 countries and one remarkable adventure – Parkinson’s campaigner Guy Deacon CBE’s documentary about his incredible African expedition aired this April on Channel 4. How do you manage living with Parkinson’s? For former army officer and father of two Guy…
Cure Parkinson’s Fundraising Heroes: March 2025
March was a busy month for Cure Parkinson’s fundraising heroes, with our supporters running, cycling and hosting community fundraisers. The community spirit Longtime Cure Parkinson’s supporter Rachel organised a flower stall ahead of Mother’s Day, where she sold beautiful bouquets and delightful flower arrangements raising…
The ASPro-PD trial is now underway
We are excited to announce that the first clinical centre for the ASPro-PD trial opened in February of this year, with the first participant enrolled earlier this month. This follows a delay to the start date due to drug reformulation issues which have now been…